Sirt2-IN-1

CAS No. 1862238-00-3

Sirt2-IN-1 ( —— )

Catalog No. M26448 CAS No. 1862238-00-3

Sirt2-IN-1 is a inhibitor of sirtuin 2 (Sirt2)(IC50 of 163 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 340 Get Quote
10MG 537 Get Quote
25MG 858 Get Quote
50MG 1161 Get Quote
100MG 1557 Get Quote
500MG 3141 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Sirt2-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Sirt2-IN-1 is a inhibitor of sirtuin 2 (Sirt2)(IC50 of 163 nM).
  • Description
    Sirt2-IN-1 is a inhibitor of sirtuin 2 (Sirt2)(IC50 of 163 nM).
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    norepinephrine reuptake; serotonin reuptake
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1862238-00-3
  • Formula Weight
    557.7
  • Molecular Formula
    C28H27N7O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc(OCc4cn(Cc5ccccc5)nn4)c3)s2)n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lancaster SG, et al. Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs. 1989 Feb;37(2):123-40.
molnova catalog
related products
  • Pristimerin

    Pristimerin has anticancer activity, treatment with Pristimerin may be a potential strategy for the suppression of hypoxia-induced metastasis through the reversal of hypoxia-induced stem cell characteristics and EMT in cancer cells.

  • RK-9123016

    RK-9123016 is a SIRT2 inhibitor. RK-9123016 increases the acetylation level of eukaryotic translation initiation factor 5A (eIF5A), a physiological substrate of SIRT2, and reduces cell viability of human breast cancer cells accompanied with a decrease in c-Myc expression.

  • Alogliptin

    Alogliptin(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9.